PINK1 phosphorylates PRKN at S65

Stable Identifier
R-HSA-9835011
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
3/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The E3 ubiquitin protein ligase parkin (PRKN) translocates to the mitochondrial outer membrane (MOM) of damaged mitochondria through a PINK1-dependent mechanism (Matsuda N et al., 2010; Narendra DP et al., 2010; VivesBauza C et al., 2010). PINK1 phosphorylates the ubiquitin-like (UBL) domain of PRKN at the S65 residue (Kondapalli C et al., 2012; Ordureau A et al., 2015; Kazlauskaite A et al., 2015; Gladkova C et al., 2018; Sauvé V et al., 2018). This process is facilitated by the PINK1-mediated phosphorylation of ubiquitin (Ub) moieties on the MOM proteins (Kane LA et al., 2014; Koyano F et al., 2014; ShibaFukushima K et al., 2014; Ordureau A et al., 2015; Kazlauskaite A et al., 2014; Zittlau K et al., 2022). Specifically, PRKN binds to phosphorylated Ub moieties (Kazlauskaite A et al., 2015) and this binding induces allosteric changes that disrupt the inhibitory interdomain interaction between the RING1 domain and the UBL domain of PRKN (Kumar A et al., 2015, 2017). The released UBL of PRKN is phosphorylated at S65 by PINK1 (Kazlauskaite A et al., 2015; Sauvé V et al., 2015) inducing a conformational change in PRKN that enhances its E3 Ub protein ligase activity (Iguchi M et al., 2013; Kondapalli C et al., 2012; Caulfield TR et al., 2014; Kazlauskaite A et al., 2015; Ordureau A et al., 2015; Aguirre JD et al., 2017; Tang MY et al., 2017; Gladkova C et al., 2018; Sauvé V et al., 2018). The conformational change is suppressed in the basal state via autoinhibited conformation (Trempe JF et al., 2013; Kumar A et al., 2015, 2017; Tang MY et al., 2017). Activated PRKN catalyzes the attachment of monoUb and/or polyUb chains to various mitochondrial proteins, marking them either for degradation via the proteasome or promoting selective removal of damaged organelles through autophagy (mitophagy).

In this Reactome event, PINK1 phosphorylates PRKN at S65.

Literature References
PubMed ID Title Journal Year
29995846 Mechanism of parkin activation by PINK1

Gladkova, C, Skehel, JM, Maslen, SL, Komander, D

Nature 2018
25969509 Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy

Duda, DM, Paulo, JA, Schulman, BA, Heo, JM, Yanishevski, D, Ordureau, A, Harper, JW, Rinehart, J, Olszewski, JL

Proc Natl Acad Sci U S A 2015
29967542 Mechanism of parkin activation by phosphorylation

Lukacs, GL, Miotto, LS, Kozlov, G, Soya, N, Blaimschein, N, Trempe, JF, Gehring, K, Sung, G, Sauvé, V

Nat Struct Mol Biol 2018
26116755 Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation

Martínez-Torres, RJ, Trost, M, Wilkie, S, Zhang, J, Hope, AG, Prescott, AR, Kazlauskaite, A, Peltier, J, Alessi, DR, Gonzalez, A, van Aalten, DM, Peggie, M, Knebel, A, Kumar, A, Muqit, MM, Walden, H, Johnson, C

EMBO Rep 2015
Participants
Participates
Catalyst Activity

protein serine/threonine kinase activity of p-S228,S402-PINK1:p-S228,S402-PINK1 [mitochondrial outer membrane]

Orthologous Events
Authored
Created
Cite Us!